Preventing cardiovascular disease in women: How can we do better?

Current Opinion in Cardiology

Volumn 27, Issue 5, 2012, Pages 542-549

  Lindquist, Ruth ^a   Witt, Dawn R ^b   Boucher, Jackie L ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

cardiovascular disease; coronary heart disease; heart disease; primary and secondary prevention; women

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AWARENESS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DISEASE COURSE; DYSLIPIDEMIA; ETHNIC GROUP; FEMALE; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH EDUCATION; HUMAN; LIFESTYLE MODIFICATION; MASS SCREENING; MENOPAUSE; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REVIEW; REYNOLDS RISK SCORE; RISK FACTOR; RISK REDUCTION; SMOKING; SMOKING CESSATION; SUDDEN DEATH; WAIST CIRCUMFERENCE;

AMERICAN HEART ASSOCIATION; CARDIOVASCULAR DISEASES; FEMALE; GUIDELINES AS TOPIC; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PRIMARY PREVENTION; RISK ASSESSMENT; SECONDARY PREVENTION; UNITED STATES; WOMEN'S HEALTH;

EID: 84865468665     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328356db70     Document Type: Review

References (56)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart Disease and Stroke Statistics: 2011 Update. Circulation 2011; 123:e18-e209.
2. World Health Organization. Cardiovascular Diseases (CVD) 2011. http://www.who.int/mediacentre/factsheets/fs317/en/index.html. [Accessed 28 April 2012]
3. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics: 2012 update - a report from the American Heart Association. Circulation 2012; 125:e2-e220.
4. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356:2388-2398. (Pubitemid 46883773)
5. Levit RD, Reynolds HR, Hochman JS. Cardiovascular disease in young women: a population at risk. Cardiol Rev 2011; 19:60-65.
6. Smith SC, Benjamin EJ, Bonow RO, et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update. Circulation 2012; 124:2458-2473.
7. Mozaffarian D, Wilson PW, Kannel WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation 2008; 117:3031-3038.
8. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation 2011; 123:1243-1262.
9. Weintraub WS, Daniels SR, Burke LE, et al., American Heart Association Advocacy Coordinating Committee; Council on Cardiovascular Disease in the Young; Council on the Kidney in Cardiovascular Disease; Council on Epidemiology and Prevention; Council on Cardiovascular Nursing; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Clinical Cardiology, and Stroke Council. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation 2011; 124:967-990.
10. Greenland P, Abrams J, Aurigemma GP, et al. Prevention Conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 2000; 101:e16-e22.
11. Lindquist R, Boucher JL, Grey EZ, et al. Eliminating untimely deaths of women from heart disease: highlights from the Minnesota Women's Heart Summit. Am Heart J 2012; 163:39-48.
12. Ali N, Lindquist R, Boucher JL, et al. Call to action: Bold ideas from the Minnesota Women's Heart Summit. Minn Med 2012; 95:44-48.
13. Vaccarino V, Badimon L, Corti R, et al. Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res 2011; 90:9-17.
14. Wenger NK. What do the 2011 American Heart Association guidelines tell us about prevention of cardiovascular disease in women? Clin Cardiol 2011; 34:520-523.
15. Wenger NK. Coronary heart disease in men and women: does 1 size fit all? No! Clin Cardiol 2011; 34:663-667.
16. Wenger NK. The female heart is vulnerable to cardiovascular disease: emerging prevention evidence for women must inform emerging prevention strategies for women. Circ Cardiovasc Qual Outcomes 2010; 3:118-119.
17. Johannes JBM, Merz CNB. Is cardiovascular disease in women inevitable? Preparing for menopause and beyond. Cardiol Rev 2011; 19:76-80.
18. DeVon HA. Promoting cardiovascular health in women across the life span. J Obstet Gynecol Neonatal Nurs 2011; 40:335-336.
19. Grammer TB, Maerz W. Are statins really useless in 'primary prevention'? Recent Cochrane meta-analysis revisited. Int J Clin Pharmacol Ther 2011; 49:293-296.
20. Wong ND. American Society for Preventive Cardiology Annual Debate: coronary heart disease in men and women - does one size fit all? Clin Cardiol 2011; 34:653.
21. Amsterdam EA. Primary prevention of coronary heart disease in men and women: does 1 size fit all? Yes! Clin Cardiol 2011; 34:658-662.
22. Maas AH, van der Schouw YT, Regitz-Zagrosek V, et al. Red alert for women's heart: the urgent need for more research and knowledge on cardiovascular disease in women: proceedings of the workshop held in Brussels on gender differences in cardiovascular disease, 29 September 2010. Eur Heart J 2011; 32:1362-1368.
23. Pina IL. Cardiovascular disease in women: challenge of the middle years. Cardiol Rev 2011; 19:71-75.
24. Davis MB, Duvernoy CS. How to stay heart healthy in 2011: considerations for the primary prevention of cardiovascular disease in women. J Womens Health 2011; 7:433-451.
25. Campos-Outcalt D. CVD prevention in women: a practice update. J Fam Pract 2011; 60:421-425.
26. Redline S, Foody J. Sleep disturbances: time to join the top 10 potentially modifiable cardiovascular risk factors? Circulation 2011; 124:2049-2051.
27. Mitka M. Some question use of statins to reduce cardiovascular risks in healthy women. JAMA 2012; 307:893-894.
28. McSweeney JC, Pettey CM, Souder E, Rhoads S. Disparities in women's cardiovascular health. J Obstet Gynecol Neonatal Nurs 2011; 40:362-371.
29. Gross R, Goral A, Muhsen K. Adherence to a healthy lifestyle and sudden cardiac death among women. JAMA 2011; 306:1861.
30. Mosca L, Barrett-Connor E, Wenger NK. Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation 2011; 124:2145-2154.
31. Arslanian-Engoren C. Women's risk factors and screening for coronary heart disease. J Obstet Gynecol Neonatal Nurs 2011; 40:337-347.
32. Vaid I, Wigington C, Borbely D, et al. WISEWOMAN: addressing the needs of women at high risk for cardiovascular disease. J Womens Health 2011; 20:977-982.
33. Kones R. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Design Dev Ther 2011; 5:325-380.
34. Berra K. Childrearing women and their families: setting the stage for heart health. Cardiol Rev 2011; 19:66-70.
35. Rheaume C, Arsenault BJ, Dumas MP, et al. Contributions of cardiorespiratory fitness and visceral adiposity to six-year changes in cardiometabolic risk markers in apparently healthy men and women. J Clin Endocr Metab 2011; 96:1462-1468.
36. Robbins CL, Dietz PM, Bombard JM, et al. Blood pressure and cholesterol screening prevalence among U.S. women of reproductive age opportunities to improve screening. Am J Prev Med 2011; 41:588-595.
37. Robbins CL, Dietz PM, Bombard J, et al. Lifestyle interventions for hypertension and dyslipidemia among women of reproductive age. Prev Chron Dis 2011; 8:A123.
38. Doering LV, Eastwood JA. A literature review of depression, anxiety, and cardiovascular disease in women. J Obstet Gynecol Neonatal Nurs 2011; 40:348-361.
39. Galbraith EM, Mehta PK, Veledar E, et al. Women and heart disease: knowledge, worry, and motivation. J Womens Health 2011; 20:1529-1534.
40. Crouch R, Wilson A, Newbury J. A systematic review of the effectiveness of primary health education or intervention programs in improving rural women's knowledge of heart disease risk factors and changing lifestyle behaviours. Int J Evidence Health 2011; 9:236-245.
41. Giardina EG, Sciacca RR, Foody JM, et al. The DHHS Office on Women's Health Initiative to Improve Women's Heart Health: focus on knowledge and awareness among women with cardiometabolic risk factors. J Womens Health 2011; 20:893-900.
42. Chiuve SE, Fung TT, Rexrode KM, et al. Adherence to a low-risk, healthy lifestyle and risk of sudden cardiac death among women. JAMA 2011; 306:62-69.
43. Liu K, Daviglus ML, Loria CM, et al. Healthy lifestyle through young adulthood and the presence of low cardiovascular disease risk profile in middle age: the Coronary Artery Risk Development in (Young) Adults (CARDIA) study. Circulation 2012; 125:996-1004.
44. Korhonen T, Goodwin A, Miesmaa P, et al. Smoking cessation program with exercise improves cardiovascular disease biomarkers in sedentary women. J Womens Health 2011; 20:1051-1064.
45. Yang Q, Cogswell ME, Flanders WD, et al. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA 2012; 307:1273-1283.
46. Parra-Medina D, Wilcox S, Salinas J, et al. Results of the Heart Healthy and Ethnically Relevant Lifestyle trial: a cardiovascular risk reduction intervention for African American women attending community health centers. Am J Public Health 2011; 101:1914-1921.
47. Taylor F, Ward K, Moore TH, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2011:004816.
48. Dorresteijn JA, Visseren FL, Ridker PM, et al. Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects. Eur Heart J 2011; 32:2962-2969.
49. Athyros VG, Ganotakis E, Kolovou GD, et al. Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative. Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women. Curr Vasc Pharmacol 2011; 9:647-657.
50. Hvelplund A, Galatius S, Madsen M, et al. Influence of distance from home to invasive centre on invasive treatment after acute coronary syndrome: a nationwide study of 24 910 patients. Heart 2011; 97:27-32.
51. Morrell J, Zeymer U, Baumgartner I, et al. Differences in management and outcomes between male and female patients with atherothrombotic disease: results from the REACH Registry in Europe. Eur J Cardiovasc Prev Rehabil 2011; 18:270-277.
52. Pittman DG, Chen W, Bowlin SJ, Foody JM. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Am J Cardiol 2011; 107:1662-1666.
53. American Heart Association and American Stroke Association. http://mylifecheck.heart.org/Multitab.aspx?NavID 1/43&CultureCode1/4en-US. [Accessed 8 May 2012]
54. Melloni C, Berger JS, Wang TY, et al. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes 2010; 3:135-142.
55. Lee LV, Foody JM. Women and heart disease. Cardiol Clin 2011; 29:35-45.
56. Leifheit-Limson EC, Reid KJ, Kasl SV, et al. The role of social support in health status and depressive symptoms after acute myocardial infarction: evidence for a stronger relationship among women. Circ Cardiovasc Qual Outcomes 2010; 3:143-150.